3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma
15
Lymphoma, Follicular
10
Hodgkin Disease
8
Lymphoma, Non-Hodgkin
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Large B-Cell, Diffuse
6
Breast Neoplasms
5
Waldenstrom Macroglobulinemia
4
Myelodysplastic Syndromes
4
Mycosis Fungoides
4
Multiple Myeloma
4
Lymphoma, T-Cell, Cutaneous
4
Leukemia
4
Sezary Syndrome
3
Neoplasms, Plasma Cell
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Neoplasms
2
Melanoma
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Liver Neoplasms
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Glioblastoma
2
Interventions
Rituximab
2
Lenalidomide
2
pegfilgrastim
1
obinutuzumab
1
acalabrutinib
1
Vincristine
1
Vascular Stiffness
1
Secondary Prevention
1
Pulse Wave Analysis
1
Prednisolone
1
Exercise
1
Eplerenone
1
Electrocardiography
1
Echocardiography
1
Doxorubicin
1
Dexrazoxane
1
Cyclophosphamide
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Heart Failure
×
Blood Specimen Collection
×
Lymphoid
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled